SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001551986-23-000024
Filing Date
2023-04-06
Accepted
2023-04-06 16:15:09
Documents
12
Period of Report
2023-03-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K nmtr-20230331.htm   iXBRL 8-K 38273
  Complete submission text file 0001551986-23-000024.txt   169603

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nmtr-20230331.xsd EX-101.SCH 1887
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nmtr-20230331_lab.xml EX-101.LAB 24849
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nmtr-20230331_pre.xml EX-101.PRE 13036
6 EXTRACTED XBRL INSTANCE DOCUMENT nmtr-20230331_htm.xml XML 4262
Mailing Address 4509 CREEDMOOR ROAD SUITE 201 RALEIGH NC 27612
Business Address 4509 CREEDMOOR ROAD SUITE 201 RALEIGH NC 27612 919-275-1933
9 METERS BIOPHARMA, INC. (Filer) CIK: 0001551986 (see all company filings)

IRS No.: 273948465 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37797 | Film No.: 23806344
SIC: 2834 Pharmaceutical Preparations